Reports for APOTEX INC
Formerly known as AA PHARMA INC
Company Name
APOTEX INC
Shortage reports
Actual shortage:
220 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
3124 (93%)
3354
Discontinuation Reports
To be discontinued:
26 (7%)
Discontinued:
343 (93%)
Reversed:
0 (0%)
369
145 (4%)
73 (30%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-PERINDOPRIL | 8MG | TABLET | Resolved | 2019-05-01 | 2019-06-08 | 82907 |
| APO-PERINDOPRIL | 8MG | TABLET | Resolved | 2022-05-13 | 2022-06-06 | 160604 |
| APO-PERINDOPRIL | 4MG | TABLET | Resolved | 2024-08-29 | 2024-09-20 | 236255 |
| APO-PERINDOPRIL | 2MG | TABLET | Resolved | 2018-08-09 | 2018-11-19 | 57802 |
| APO-PERINDOPRIL | 4MG | TABLET | Resolved | 2022-05-27 | 2022-08-11 | 161451 |
| APO-PERINDOPRIL-INDAPAMIDE | 1.25MG 4MG | TABLET | Resolved | 2023-02-09 | 2023-09-22 | 184092 |
| APO-PERINDOPRIL-INDAPAMIDE | 1.25MG 4MG | TABLET | Resolved | 2024-12-19 | 2025-01-17 | 246056 |
| APO-PERINDOPRIL-INDAPAMIDE | 8MG 2.5MG | TABLET | Avoided shortage | 2023-03-09 | 2023-09-15 | 186580 |
| APO-PERINDOPRIL-INDAPAMIDE | 8MG 2.5MG | TABLET | Resolved | 2022-04-29 | 2022-06-28 | 159713 |
| APO-PERINDOPRIL-INDAPAMIDE | 8MG 2.5MG | TABLET | Resolved | 2023-03-09 | 2023-09-22 | 186583 |
| APO-PERINDOPRIL-INDAPAMIDE | 8MG 2.5MG | TABLET | Resolved | 2024-08-15 | 2025-02-07 | 235342 |
| APO-PERINDOPRIL-INDAPAMIDE | 1.25MG 4MG | TABLET | Resolved | 2024-07-25 | 2024-11-22 | 233709 |
| APO-PERINDOPRIL-INDAPAMIDE | 1.25MG 4MG | TABLET | Resolved | 2022-09-01 | 2022-09-23 | 168424 |
| APO-PERINDOPRIL-INDAPAMIDE | 1.25MG 4MG | TABLET | Actual shortage | 2025-03-27 | 2025-05-01 | 253496 |
| APO-PERINDOPRIL-INDAPAMIDE | 8MG 2.5MG | TABLET | Resolved | 2024-06-20 | 2024-11-22 | 231027 |
| APO-PERINDOPRIL-INDAPAMIDE | 1.25MG 4MG | TABLET | Resolved | 2023-07-13 | 2023-12-22 | 198505 |
| APO-PERINDOPRIL-INDAPAMIDE | 8MG 2.5MG | TABLET | Resolved | 2023-10-27 | 2024-02-09 | 208411 |
| APO-PERINDOPRIL/AMLODIPINE | 10MG 14MG | TABLET | Resolved | 2024-04-05 | 2024-04-19 | 224586 |
| APO-PERINDOPRIL/AMLODIPINE | 7MG 5MG | TABLET | Resolved | 2020-04-22 | 2020-04-28 | 112741 |
| APO-PERINDOPRIL/AMLODIPINE | 10MG 14MG | TABLET | Resolved | 2023-10-20 | 2023-10-27 | 207704 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-FENTANYL MATRIX | 25MCG | PATCH | Discontinued | 2018-09-07 | 2018-09-15 | 60489 |
| APO-FENTANYL MATRIX | Discontinued | 2018-09-07 | 2018-09-15 | 60494 | ||
| APO-FENTANYL MATRIX | 75MCG | PATCH | Discontinued | 2018-09-07 | 2018-09-15 | 60497 |
| APO-FENTANYL MATRIX | 100MCG | PATCH | Discontinued | 2018-02-23 | 2018-12-28 | 40741 |
| APO-FLUNISOLIDE NASAL SPRAY | 0.25MG | METERED-DOSE PUMP | Discontinued | 2018-02-26 | 2018-02-26 | 40965 |
| APO-FLUVOXAMINE TABLETS | 100MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4713 |
| APO-FLUVOXAMINE TABLETS | 50MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4716 |
| APO-GAIN LIQ 20MG/ML | 20MG | SOLUTION | Discontinued | 2018-02-26 | 2018-02-26 | 40997 |
| APO-GAIN LIQ 20MG/ML | 20MG | SOLUTION | Discontinued | 2019-01-02 | 2019-01-02 | 70815 |
| APO-GEMFIBROZIL | 600MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4927 |
| APO-GEMFIBROZIL CAP 300MG USP | Discontinued | 2019-06-12 | 2019-06-12 | 86557 | ||
| APO-GEMFIBROZIL CAP 300MG USP | 300MG | CAPSULE | Discontinued | 2017-03-31 | 2018-12-07 | 4920 |
| APO-GLICLAZIDE | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60512 |
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94452 | ||
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94446 | ||
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94449 | ||
| APO-HALOPERIDOL TAB 2MG | 2MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1084 |
| APO-HALOPERIDOL TAB 5MG | 5MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1087 |
| APO-HYDROMORPHONE CR | 24MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110968 |
| APO-HYDROMORPHONE CR | 30MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110971 |